ASTEC LIFESCIENCES LOOKING GOOD NOW 970- 976
SUPPORT 770
VIEW ONLY FOR SHORT TO LONG-TERM
TARGET EXPECTING 2280, 3100++
Astec Lifesciences Share Price: Introduction
Astec Lifesciences Ltd. is a prominent player in the pesticides and agrochemicals sector. As investors, understanding the dynamics of its share price is crucial. In this blog, we’ll explore critical aspects of Astec Lifesciences, including its financials, stock performance, and factors that influence its valuation.
Astec Lifesciences Share Price:
Company Profile:
Astec Lifesciences Limited is a holding company incorporated in 1993. It produces agrochemicals and pharmaceutical intermediates. The company’s registered office is in Mumbai, Maharashtra, India.
Holdings:
- Promoters:
66.75% (As of the December 2023 quarter) - Foreign Institutional Investors (FII):
1.28% (As of the December 2023 quarter) - Domestic Institutional Investors (DII):
8.77% (As of the December 2023 quarter)Mutual Funds:
8.77% (As of the December 2023 quarter)
Recent Shareholding Changes:
- Promoter holding remains unchanged at 66.75% in the December 2023 quarter.
- FII/FPI holdings decreased from 1.33% to 1.28% in the December 2023 quarter. FII/FPI investors decreased from 32 to 30 in the same quarter.
- Mutual fund holdings decreased from 9.15% to 8.77% in the December 2023 quarter. However, MF schemes increased from 4 to 5 in the same quarter.
Additional Information:
- The company has a high promoter holding of 66.75%.
- The company’s PEG ratio is 0.51.
- The company has shown a poor profit growth of -18.69% for the past three years.
- The company has demonstrated low revenue growth of 6.35% for the past three years.
Astec Lifesciences Share Price: Financial Snapshot
Earnings Per Share (EPS)
Astec Lifesciences has witnessed fluctuations in its EPS over the years. As of the latest data, the EPS stands at Rs. 28 for the fiscal year 2023. This metric reflects the company’s profitability and growth potential.
Valuation Metrics
- Price-to-Earnings (P/E) Ratio:Currently, Astec Lifesciences trades at a P/E ratio of
34.95. A lower P/E ratio suggests undervaluation, making it an attractive investment proposition.
- Price-to-Book (P/B) Ratio:
The P/B ratio is 4.40, indicating that the stock is reasonably priced relative to its book value.Astec Lifesciences Share Price: Stock Performance
52-Week High and Low
Astec Lifesciences hit a 52-week high of Rs. 1,541.65 and a 52-week low of Rs. 825.05. These extremes provide insights into the stock’s volatility and potential entry points.
Current Share Price
As of the most recent data, Astec Lifesciences is trading at Rs. 894.25. This represents a 1.45% increase from the previous closing price of Rs. 881.501.
Astec Lifesciences Share Price: Factors Affecting
Several factors significantly influence Astec Lifescience’s share price, and understanding these dynamics is crucial for informed investment decisions. Here are some key factors:
- Industry Trends:
The overall health of the Indian agrochemicals and pharmaceutical intermediates sector directly impacts Astec Lifescience’s share price. Factors like government regulations, competition, and product demand significantly influence the company’s performance and, consequently, its share price. - Financial Performance:
Astec Lifesciences’ financial health, including revenue, profit margins, and debt levels, is crucial in determining investor confidence and influencing the share price. - Company News and Announcements:
Any significant news or announcements from the company, such as new product launches, acquisitions, or partnerships, can trigger fluctuations in the share price. - Market Sentiment:
Broader market sentiment, including domestic and global economic factors, can also impact investor confidence and, thereby, Astec Lifescience’s share price.
Astec Lifesciences Share Price: Investment Considerations
Strengths-
Cash Flow:
Astec Lifesciences generates vital cash from its core business, and improving cash flow over the last two years is a positive sign.
Weaknesses
Shareholding Decrease:
Mutual funds reduced their shareholding in the last quarter. Investors should monitor this trend closely.
Opportunities-
Low P/E:
The stock’s P/E ratio is below 10, making it attractive for value investors.
Threats-
Rising Costs:
Companies with growing costs for long-term projects pose a risk to Astec Lifesciences.
Forecast and Analyst Ratings-
Analysts’ consensus suggests a mixed outlook for Astec Lifesciences. While some recommend buying, others advise caution. As an investor, please consider your risk tolerance and investment horizon when making these recommendations.
READ MORE: Adani Power Share Price: Analysis and Investment Recommendations
Conclusion
Astec Lifesciences is a company with potential, but it also faces challenges. As you evaluate investment opportunities, monitor its financials, industry trends, and external factors. Remember that effective investment requires careful study and a long-term outlook.
This blog is simply a source of information. Always consult with a financial advisor before making any investment decisions. Happy investing! 📈🌱